CONTEXT: Changes in cortisol metabolism due to altered activity of the enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD) have been implicated in the pathogenesis of hypertension, obesity and the metabolic syndrome. No published data exist on the activity of this enzyme in critical illness. OBJECTIVE: To investigate cortisol metabolism in critically ill patients utilising plasma cortisol: cortisone ratio as an index of 11beta-HSD activity. SETTING: Tertiary level intensive care unit. PATIENTS: Three cohorts of critically ill patients: sepsis (n = 13); multitrauma (n = 20); and burns (n = 19). MAIN OUTCOME MEASURES: Serial plasma cortisol: cortisone ratios. MEASUREMENTS AND MAIN RESULTS: Plasma total cortisol cortisone ratios were determined serially after admission to the intensive care unit. As compared with controls, the plasma cortisol:cortisone ratio was significantly elevated in the sepsis and trauma cohorts on day 1 (22 +/- 9, p = 0.01, and 23 +/- 19, p = 0.0003, respectively) and remained elevated over the study period. Such a relationship was not demonstrable in burns. The ratio was significantly correlated with APACHE II (r = 0.77, p = 0.0008) and Simplified Acute Physiology Score (r = 0.7, p = 0.003) only on day 7 and only in the burns cohort. There were no significant correlations observed between total plasma cortisol or cortisone and sickness severity in the sepsis and trauma cohorts. CONCLUSIONS: In critically ill patients, there is evidence of altered cortisol metabolism due to an increase in 11beta-HSD activity as demonstrated by an elevation of plasma cortisol: cortisone ratios. Further studies with larger sample sizes specifically designed to examine altered tissue 11beta-HSD activity and its clinical significance and correlation with outcome are warranted.
CONTEXT: Changes in cortisol metabolism due to altered activity of the enzyme 11beta-hydroxysteroid dehydrogenase (11beta-HSD) have been implicated in the pathogenesis of hypertension, obesity and the metabolic syndrome. No published data exist on the activity of this enzyme in critical illness. OBJECTIVE: To investigate cortisol metabolism in critically illpatients utilising plasma cortisol: cortisone ratio as an index of 11beta-HSD activity. SETTING: Tertiary level intensive care unit. PATIENTS: Three cohorts of critically illpatients: sepsis (n = 13); multitrauma (n = 20); and burns (n = 19). MAIN OUTCOME MEASURES: Serial plasma cortisol: cortisone ratios. MEASUREMENTS AND MAIN RESULTS: Plasma total cortisolcortisone ratios were determined serially after admission to the intensive care unit. As compared with controls, the plasma cortisol:cortisone ratio was significantly elevated in the sepsis and trauma cohorts on day 1 (22 +/- 9, p = 0.01, and 23 +/- 19, p = 0.0003, respectively) and remained elevated over the study period. Such a relationship was not demonstrable in burns. The ratio was significantly correlated with APACHE II (r = 0.77, p = 0.0008) and Simplified Acute Physiology Score (r = 0.7, p = 0.003) only on day 7 and only in the burns cohort. There were no significant correlations observed between total plasma cortisol or cortisone and sickness severity in the sepsis and trauma cohorts. CONCLUSIONS: In critically illpatients, there is evidence of altered cortisol metabolism due to an increase in 11beta-HSD activity as demonstrated by an elevation of plasma cortisol: cortisone ratios. Further studies with larger sample sizes specifically designed to examine altered tissue 11beta-HSD activity and its clinical significance and correlation with outcome are warranted.
Authors: G Dickstein; C Shechner; W E Nicholson; I Rosner; Z Shen-Orr; F Adawi; M Lahav Journal: J Clin Endocrinol Metab Date: 1991-04 Impact factor: 5.958
Authors: J T Ho; H Al-Musalhi; M J Chapman; T Quach; P D Thomas; C J Bagley; J G Lewis; D J Torpy Journal: J Clin Endocrinol Metab Date: 2005-11-01 Impact factor: 5.958
Authors: Marcus Quinkler; Daniel Zehnder; Julia Lepenies; Massimiliano D Petrelli; Jasbir S Moore; Susan V Hughes; Paul Cockwell; Martin Hewison; Paul M Stewart Journal: Eur J Endocrinol Date: 2005-08 Impact factor: 6.664
Authors: Jerry J Zimmerman; Amy Donaldson; Ruth M Barker; Kathleen L Meert; Rick Harrison; Joseph A Carcillo; Kanwaljeet J S Anand; Christopher J L Newth; John Berger; Douglas F Willson; Rhona Jack; Carol Nicholson; J Michael Dean Journal: Pediatr Crit Care Med Date: 2011-09 Impact factor: 3.624
Authors: Jeremy Cohen; Renae Deans; Andrew Dalley; Jeff Lipman; Michael S Roberts; Bala Venkatesh Journal: Crit Care Date: 2009-11-27 Impact factor: 9.097
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2008-01-04 Impact factor: 17.440